HeartSciences (HSCS) Proxy filing summary

Executive summary

• Fortitude and the issuer entered a definitive agreement for an all-stock merger, combining Fortitude’s Zcash-anchored digital-asset mining platform with an AI-powered medical technology business.

• Definitive proxy materials were filed October 19, 2026 and mailed to shareholders eligible to vote at a special meeting; additional transaction materials may be filed.

Voting matters and shareholder proposals

• Completion depends on requisite shareholder approval and other closing conditions; failure to obtain approval could prevent or delay the transaction.

• Shareholders were urged to review the definitive proxy statement, any amendments or supplements, and other relevant SEC filings before making a voting or investment decision.

Risk oversight and compliance

• Transaction risks include closing delays or failure, integration and management of a newly public business, adverse market conditions, and volatility in Zcash and other cryptocurrencies.

• Digital assets carry significant legal, commercial, regulatory, and technical uncertainty; actual results may differ materially from forward-looking statements, and the parties disclaim an update obligation except as required by law.

• Fortitude and affiliates, including DCG, may sell, pledge, or otherwise monetize digital assets; proceeds fund operating expenses, capital investments, hedging, and investment gains.

• A social media post reposted by Barry Silbert highlighted ZEC’s price action, privacy narrative, and performance at market reversals; a separate post described six weeks of ZEC consolidation.